Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amicus Therapeutics (FOLD) Exchange Rate Effect (2016 - 2025)

Amicus Therapeutics (FOLD) has disclosed Exchange Rate Effect for 10 consecutive years, with -$329000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Exchange Rate Effect fell 110.59% year-over-year to -$329000.0, compared with a TTM value of $13.3 million through Dec 2025, up 429.37%, and an annual FY2025 reading of $13.3 million, up 429.37% over the prior year.
  • Exchange Rate Effect was -$329000.0 for Q4 2025 at Amicus Therapeutics, up from -$1.2 million in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $18.5 million in Q4 2022 and bottomed at -$20.7 million in Q3 2022.
  • Average Exchange Rate Effect over 5 years is -$205500.0, with a median of -$1.0 million recorded in 2021.
  • The sharpest move saw Exchange Rate Effect plummeted 3076.57% in 2022, then skyrocketed 3496.94% in 2025.
  • Year by year, Exchange Rate Effect stood at -$908000.0 in 2021, then surged by 2137.56% to $18.5 million in 2022, then tumbled by 121.11% to -$3.9 million in 2023, then skyrocketed by 179.54% to $3.1 million in 2024, then plummeted by 110.59% to -$329000.0 in 2025.
  • Business Quant data shows Exchange Rate Effect for FOLD at -$329000.0 in Q4 2025, -$1.2 million in Q3 2025, and $10.0 million in Q2 2025.